Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Babraham Institute


Contact Details:
Babraham
Cambridge
Cambridgeshire
CB2 4AT
United Kingdom
Tel:00 44 1223 496 510
Fax:
Email:

Loading...

Recent Publications by Babraham Institute:

Cross-talk between phospholipase D and MAP kinases activities.
Protein microarrays are versatile tools for parallel, miniaturized...
10th November, 2009
Inositide Laboratory, The Babraham Institute, Babraham, Cambridge CB22 Adv Enzyme Regul. 2009 Nov 5.
DOI Direct Link
Effects of anesthetic agents on socially transmitted olfactory memories in mice.
Mice can learn a food preference from odor cues transmitted on the breath...
3rd November, 2009
Cognitive and Systems Neuroscience, Babraham Institute, Babraham, Neurobiol Learn Mem. 2009 Oct 29.
DOI Direct Link
De-regulated FGF receptors as therapeutic targets in cancer.
Fibroblast growth factors (FGFs) acting through their cognate receptors...
31st October, 2009
Laboratory of Molecular Signalling, The Babraham Institute, Babraham Pharmacol Ther. 2009 Oct 27.
DOI Direct Link
Apoptosis and autophagy: BIM as a mediator of tumour cell death in response to oncogene-targeted therapeutics.
The BCL-2 homology domain 3 (BH3)-only protein, B-cell lymphoma 2...
29th October, 2009
Laboratory of Molecular Signalling, The Babraham Institute, Babraham FEBS J. 2009 Nov;276(21):6050-62. Epub 2009 Sep 29.
DOI Direct Link
Inhibition of nitric oxide-activated guanylyl cyclase by calmodulin antagonists.
BACKGROUND AND PURPOSE: Nitric oxide (NO) controls numerous physiological...
23rd October, 2009
Babraham Institute, Cambridge, UK. Br J Pharmacol. 2009 Nov;158(6):1454-64. Epub 2009 Oct 20.
DOI Direct Link

View more Babraham Institute research publications.

Press Releases on Babraham Institute:

BioPortfolio Logo
Crescendo Biologics Raises GBP4.5 million in Seed-Funding Led by Sofinnova Partners 12th October, 2009
CAMBRIDGE, England, October 12 /PRNewswire/ -- Crescendo Biologics ("Crescendo") today announces it has raised GBP4.5 million in a seed-funding round to advance the development of its
Cyntellect Appoints Former Millipore and BD Biosciences Executives to Head Up its Product Marketing Efforts 15th January, 2009 Cyntellect, Inc.
New hires bring over 25 years of life sciences marketing experience to Cyntellect SAN DIEGO, Jan. 15 /PRNewswire/ -- Cyntellect, a privately-held life sciences company leading the development and
CellCentric receives new funding and links up with the Babraham Institute 1st May, 2004 Cellcentric
CellCentric receives new funding and links up with the Babraham Institute Cambridge, UK. 7 April 2005…CellCentric, a leading company in the exploitation of epigenetics, announces that it
CellCentric receives new funding from NESTA to further its work in 1st May, 2004 Cellcentric
CellCentric receives new funding from NESTA to further its work in epigenetics and cancer Cambridge, UK, 5 September 2005… CellCentric, a leading
CellCentric and Cancer Research Technology initiate co-development 1st May, 2004 Cellcentric
CellCentric and Cancer Research Technology initiate co-development partnership Cambridge, UK. 26th September  2005… CellCentric, a leading

BioNews Results for Babraham Institute:

Crescendo Biologics Raises GBP4.5 million in Seed-Funding Led by Sofinnova Partners
Genetic Engineering News:  Oct 12 2009 9:23AM Matching: babraham institute
Crescendo Biologics Raises GBP 4.5 Million in Seed-Funding Led by Sofinnova Partners
BioSpace:  Oct 12 2009 6:38PM Matching: babraham institute
Crescendo Biologics Raises GBP4.5 million in Seed-Funding Led by Sofinnova Partners
KOTA Territory News:  Oct 12 2009 4:06PM Matching: babraham institute
Crescendo Biologics Raises GBP4.5 million in Seed-Funding Led by Sofinnova Partners
Pharma Live:  Oct 12 2009 2:58PM Matching: babraham institute
Crescendo Biologics Raises GBP4.5 million in Seed-Funding Led by Sofinnova Partners
SmartBrief:  Oct 12 2009 12:43PM Matching: babraham institute
Promote your company here: BioNewsCast - Press Release Distribution

View more Babraham Institute news.

Babraham Institute Patents:

US Patent No.Title
7029910 Immunoglobulin control region
6998514 Murine expression of a human IgA lambda locus
6436701 Derivation of pluripotential embryonic cell lines from ungulate species
6348349 Yeast artificial chromosomes and their use in the control of gene expression
6017763 G-beta-gamma regulated phosphatidylinositol-3' kinase

View more Babraham Institute patents.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 318 individuals from Babraham Institute using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 1018 times since April 2007, the link to the organisation's website has been followed 0 times

Recent Search Terms used to find this page: Pflugers Arch. 2009 Oct 1 alzheimer s | Chromatin and Gene Expression Department The Babraham Institute Cambridge UK | rbs babraham | Adv Exp Med Biol 2009 650 59-72 | Adv Exp Med Biol 2009 650 | babraham institute logo | Department of Neurobiology The Babraham Institute | babraham institute logo | companies at babraham institute | babraham institute | .

Search for more companies in Cambridge

Search for more companies in Cambridgeshire



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Babraham Institute

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.